1-3 of 3
Clay A. Smith, MD
Close
Sort by
Journal Articles

Septicemia in Chemotherapy Induced Neutropenic Acute Myeloid Leukemia (AML) Inpatients and Outpatients: A 5 Year Retrospective Experience.

Timotheus Y. Halim, Julye C. Lavoie, MD, Micheal J. Barnett, MD, Donna L. Forest, MD, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, Thomas J. Nevill, MD, John D. Shepherd, MD, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, Clay A. Smith, MD
Journal: Blood
Blood (2004) 104 (11): 4525.
https://doi.org/10.1182/blood.V104.11.4525.4525
Published: 2004
Journal Articles

Campath-1H May Have Activity in the Treatment of Multiple Myeloma.

Cristina Gasparetto, MD, Mitchell E. Horwitz, MD, Jon P. Gockerman, MD, Carlos M. de Castro, MD, Joseph O. Moore, MD, Clay A. Smith, MD, Patty Davis, Martha Lassiter, Lesa Houser, Nelson J. Chao, MD, David Rizzieri, MD
Journal: Blood
Blood (2004) 104 (11): 4931.
https://doi.org/10.1182/blood.V104.11.4931.4931
Published: 2004
Journal Articles

High Risk AML Outpatient Management: A Retrospective Analysis of Bacteremia Incidence Following Chemotherapy.

Timotheus Y. Halim, Julye C. Lavoie, MD, Michael J. Barnett, MD, Stephen H. Nantel, MD, Thomas J. Nevill, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Donna E. Hogge, MD, PhD, Kevin W. Song, MD, Donna L. Forrest, MD, Cynthia L. Toze, MD, Clay A. Smith, MD
Journal: Blood
Blood (2004) 104 (11): 884.
https://doi.org/10.1182/blood.V104.11.884.884
Published: 2004